Search

Search Results
Results 321 - 330 of 337 for Active movement
  • Imatinib-Teva
    Drug - 9 Jan 2023
    Consumer Medicine Information (CMI) about Imatinib-Teva intended for persons living in Australia.
  • Telzir Tablets
    Drug - 23 Dec 2022
    Consumer Medicine Information (CMI) about Telzir Tablets intended for persons living in Australia.
  • Retrovir
    Drug - 2 Dec 2022
    Consumer Medicine Information (CMI) about Retrovir intended for persons living in Australia.
  • Mogadon
    Drug - 3 Nov 2022
    Consumer Medicine Information (CMI) about Mogadon intended for persons living in Australia.
  • Atrovent Metered Dose Inhaler
    Drug - 29 Aug 2022
    Consumer Medicine Information (CMI) about Atrovent Metered Dose Inhaler intended for persons living in Australia.
  • Lumakras
    Drug - 14 Jun 2022
    Consumer Medicine Information (CMI) about Lumakras intended for persons living in Australia.
  • DBL Papaverine Hydrochloride
    Drug - 23 Mar 2022
    Consumer Medicine Information (CMI) about DBL Papaverine Hydrochloride intended for persons living in Australia.
  • Eraxis
    Drug - 15 Oct 2021
    Consumer Medicine Information (CMI) about Eraxis intended for persons living in Australia.
  • Rukobia Tablets
    Drug - 5 Aug 2021
    Consumer Medicine Information (CMI) about Rukobia Tablets intended for persons living in Australia.
  • Sevorane
    Drug - 20 Nov 2020
    Consumer Medicine Information (CMI) about Sevorane intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback